The circadian clock gene BMAL1 increases radiosensitivity in nasopharyngeal carcinoma cell CNE2

Objective To investigate the involvement of the circadian clock gene BMAL1 in regulating radiosensitivity in nasopharyngeal carcinoma (NPC). Methods The regulatory role of BMAL1 in NPC radiotherapy was investigated using 44 NPC cases and the NPC cell line CNE2, which had been genetically modified to either overexpress or silence BMAL1. Infected CNE2 cells were divided into four groups, including those with BMAL1 overexpression and BMAL1 RNA interference (RNAi), as well as their respective control groups. The group responses to different doses of radiotherapy were examined. Results The 5-year survival rates of the BMAL1 overexpression group demonstrated a significant increase compared to those of the low expression group (p < 0.05). Furthermore, the BMAL1 overexpression group exhibited a higher tumor-growth inhibition rate (p < 0.001) and apoptotic rate (p = 0.004) following radiotherapy; a decreased proportion of S-phase cells (p < 0.001) but an increased proportion of G2/M-phase cells (p = 0.001) after 24 h of 8Gy irradiation; reduced number of cell colonies (p = 0.042), and a lower survival score (p = 0.037). Conclusions Our findings demonstrate a positive correlation between BMAL1 expression and NPC survival, suggesting that BMAL1 promotes NPC radiosensitivity.